AHCO · NASDAQ · Health Care Equipment
Health Care Equipment company based in Plymouth Meeting, Pennsylvania.
In the last 90 days, insiders of AdaptHealth Corp. reported 4 open-market purchases worth about $521K and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 5, 2026
$5.74
Last 12 months
Not enough history
Market value
$783M
Revenue
$740M
+12.7% vs the same quarter a year earlier
Free cash flow, last 12 months
$97.7M
This quarter −$20.9M, a year earlier $73.3M
Net debt
—
Debt $1.89B, cash —, at Jun 30, 2026
Net income, last 12 months
−$228M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 4, 2026.
Insiders buying, last 90 days
2 insiders
$521K bought in total
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$3.24B
−0.5% vs the year before
Net income, fiscal 2025
−$70.8M
A loss for the year
Shares outstanding
136M
As of Jul 31, 2026
Stock since the trade −5.0% · S&P 500 +0.8% · to Oct 5
A board member of AdaptHealth paid $126K out of pocket for AdaptHealth shares. 1 other person at AdaptHealth bought some too, in the same month. It was the first purchase in 6 months.
Stock since the trade −5.0% · S&P 500 +0.8% · to Oct 5
A board member of AdaptHealth paid $150K out of pocket for AdaptHealth shares. 1 other person at AdaptHealth bought some too, in the same month. The AdaptHealth shares held grew by 94%.
Dale B Wolf · Traded Aug 6 – Aug 7, 2026 · largest single filing ~$127K
Aug 7, 2026~$117K · 20K sh @ $5.86
DetailsOfficial recordAug 6, 2026~$127K · 20K sh @ $6.37
DetailsOfficial recordOfficer sold ~$118K of AdaptHealth Corp.
Scheduled in advancePrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Top officer leaving
“Chief Financial Officer Departure The Company announced today that Jason Clemens, the Company’s Chief Financial Officer, will terminate his employment with the Company effective as of October 1, 2026 (the “Separation Date”);”
8-K on sec.govDisclosed a material cybersecurity incident
1 insider sold ~$231K in the 60 days before
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Last 12 months, adjusted daily closes
Adjusted close went from $8.96 on Oct 6, 2025 to $5.74 on Oct 5, 2026 (-35.9%). Disclosed activity in the last 12 months: 16 insider purchases, 3 insider sales (2 under pre-arranged plans), 0 Congress purchases, 0 Congress sales. 3 groups of purchases by several insiders within a few days.